MarketPeel
Insider Trading Intelligence
CK

Chaitan Phd Khosla

PTGX
DIRECTOR · PROTAGONIST THERAPEUTICS, INC · CIK 0001135139
FILING MIX · LIFETIME60%/40%
BUYS
3
SELLS
2
TOTAL VALUE
$47.7K
COMPANIES
1
ACTIVE SINCE
Aug 2019
HOLDINGS NOW
2,499
AVG SELL PX
$17.19
TRADE KIND
SHOWING 5 / 5
Trades · vs SPY
Loading price series…
Performance · forward returns vs SPY
1 backtested trades · 8 horizonsHow are these numbers computed? →
Forward-return performance of every backtestable P/S trade by Chaitan Phd Khosla, measured at 8 horizons from 7 days to 2 years. Deduped per economic event so co-filings count once. Excess return = trade return minus SPY return over the same window.
HORIZONTRADESWIN RATEINSIDER RETURNSPY RETURNMEAN EXCESSMEDIAN EXCESST-STAT
7d1+0.00%+7.43%+1.76%+5.67%+5.67%
14d1+0.00%+31.72%+3.41%+28.32%+28.32%
30d1+0.00%+26.06%+0.33%+25.73%+25.73%
60d1+0.00%+24.65%+4.64%+20.00%+20.00%
90d1+0.00%+26.89%+6.97%+19.91%+19.91%
180d1+0.00%+45.28%+18.32%+26.97%+26.97%
1y1+0.00%+183.02%+35.34%+147.68%+147.68%
2y1+100.00%-38.68%+29.91%-68.59%-68.59%
How to read this: Insider Returnis the average raw return of the filer's trades over the horizon. SPY Return is what SPY did over those same windows — reference only, not a comparison. The headline alpha number is Mean Excess = Insider − SPY; green means the filer beat SPY, red means they trailed it. Win rate is the share of individual trades where the filer beat SPY. T-statvalues above 2 mean the alpha is unlikely to be chance given the sample size. "Pending" counts trades where the horizon hasn't elapsed yet; their stats are not included in the row average.
Holdings over time
PTGX · 2,499 shares · as of Aug 11, 2020
03,7507,50011,25015,0002020SHARES HELD
Trading cadence · quarterly flow
BUY SELL
2019
2019
2020
2020
2020
FLOW · 3 buys / 2 sellsCOVERAGE · 5 quarters
Form 4 filings · all activity
COMPANYTYPESHARESPRICEVALUEHELD AFTERTRADE DATEFILEDDETAILS
PTGX
PROTAGONIST THERAPEUTICS, INC
SALE
2,4997,499Aug 11, 2020Aug 12, 2020View →
PTGX
PROTAGONIST THERAPEUTICS, INC
SALE
2,499$17.19$43.0K0Aug 11, 2020Aug 12, 2020View →
PTGX
PROTAGONIST THERAPEUTICS, INC
PURCHASE
2,499$1.89$4.7K2,499Aug 11, 2020Aug 12, 2020View →
PTGX
PROTAGONIST THERAPEUTICS, INC
PURCHASEGRANT
Stock grant
15,00015,000May 28, 2020May 29, 2020View →
PTGX
PROTAGONIST THERAPEUTICS, INC
PURCHASEGRANT
Stock grant
5,0005,000Aug 15, 2019Apr 8, 2020View →
Other insiders · PTGX
Loading peer insiders…
About this filer
CIK 0001135139
ROLE
Director
PRIMARY
PTGX
COMPANIES
1
ACTIVE SINCE
Aug 2019
MARKETPEEL · /INSIDER/0001135139DATA · SEC EDGAR · FORM 4 · CONSOLIDATED TAPE
FREE · DAILY · 6 AM ET

One short email. Insider buys, congressional trades, and plain-English analysis.

Feedback